Publication | Closed Access

Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer

Second-line TreatmentMedicineSingle-agent GemcitabinePharmacologyPrevious ChemotherapyCombined Modality TreatmentAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung Cancer